Assertio Holdings, Inc. Common Stock
Symbol: ASRT (NASDAQ)
0.00
▼ (-100.00%) -0.810
Company Description:
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $0.81
- Yesterday High: $0.833
- Yesterday Low: $0.8092
- Yesterday Volume: 184.32K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Assertio Holdings, Inc. Common Stock
- Website: https://www.assertiotx.com
- Listed Date: 1997-11-05
- Location: LAKE FOREST, IL
- Market Status: Active
- CIK Number: 0001808665
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $79.90M
- Round Lot: 100
- Outstanding Shares: 96.24M
- Asset Type: CS
RECENT FILINGS FOR ASRT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-10 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-06-03 | 4 | View |
| 2025-05-19 | S-8 | View |
| 2025-05-14 | 4 | View |
| 2025-05-14 | 4 | View |
| 2025-05-14 | 4 | View |
| 2025-05-13 | 8-K | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | 4 | View |
| 2025-05-09 | 4 | View |
| 2025-04-09 | ARS | View |
| 2025-04-08 | DEF 14A | View |
| 2025-03-25 | PRE 14A | View |
| 2025-03-12 | 10-K | View |
Latest News on ASRT